Skip to main content

Table 11 Pharmacokinetic studies of pure EZ solution and combination of EZ and Piperine solution

From: Characterization and interactions between piperine and ezetimibe in their Anti-hyperlipidemic efficacy using Biopharmaceutics and Pharmacokinetics

Pharmacokinetic Parameters

EZ solution

Piperine solution

EZ and piperine solution

Intercept

1.278799

1.560009

1.820917

Slope

-0.03723

-0.01811

-0.02158

Co (mcg/mL)

19.00198

36.30855

66.20892

K (hr-1)

0.085744

0.041701

0.049706

Dose (mg)

10

10

10

Dose (mcg)

10,000

10,000

10,000

Vd (mL)

526.261 ± 3.56

275.4172 ± 1.46

151.037 ± 1.62

Vd (L)

0.526261 ± 0.25

0.275417 ± 0.26

0.151037 ± 0.95

t1/2 (hr)

8.082205 ± 0.64

16.61823 ± 0.48*

13.94199 ± 0.15**

Cl (L/hr)

45.12369 ± 1.62

11.48523 ± 0.16*

7.507444 ± 0.33**

AUC-o-t (mcg.hr/mL)

4.875494 ± 0.52

9.202138 ± 0.95

16.67723 ± 1.42

AUC 1-t (mcg.hr/mL)

202.0825 ± 0.16

573.825 ± 0.67

1053.75 ± 0.62

AUC 1-inf(mcg.hr/mL)

29.03996 ± 0.82

323.2522 ± 1.35

391.5022 ± 0.54

AUC total (mcg.hr/mL)

235.998 ± 3.74

906.2793 ± 2.48

1461.929 ± 2.34

Cmax (mcg.hr/mL)

24.36 ± 0.62

61.25 ± 0.95

159.86 ± 1.46**

Tmax (mL/min)

1.95 ± 0.49

3.25 ± 0.18

4.36 ± 0.26*

  1. Values are expressed as mean ± (± standard deviation) pharmacokinetic parameters (n = 6). *p < 0.01 and **p < 0.05 considered statistically significant as compared to EZ solution